显示标签为“treatment for Stage 3 CKD”的博文。显示所有博文
显示标签为“treatment for Stage 3 CKD”的博文。显示所有博文

2015年1月18日星期日

Treatment for Stage 3 CKD is a serious health problem

Treatment for Stage 3 CKD
Treatment for Stage 3 CKD is a serious health problem, often associated with other common chronic diseases such as diabetes, hypertension, and cardiovascular disease (CVD)2 and an estimated 1:10 British Columbians has some form of significant kidney disease.3

Staging of CKD is now determined by the combined results of kidney function (eGFR) and the level of albuminuria.

There are many different types and causes of kidney disease. These can be characterized as hereditary, congenital or acquired.
Diabetes is the leading cause Treatment for Stage 3 CKD and is associated with excessive cardiovascular morbidity and mortality (1,2). Anemia is common among those with diabetes and Treatment for Stage 3 CKD and greatly contributes to patient outcomes (3,4). Observational studies indicate that low Hb levels in such patients may increase risk for progression of kidney disease and cardiovascular morbidity and mortality (5). Controlled clinical trials of anemia treatment with erythropoietin stimulating agents (ESAs) demonstrated improved quality of life (QOL) but have not demonstrated improved outcomes (6–10).
Treatment for Stage 3 CKD amplifies risk for multiple conditions: cardiac morbidity and mortality risk is elevated 10 times that of population mean risk;4,5 length of hospital stay and adverse reactions to drugs are also increased;6-10 and renal replacement therapy (RRT) is only one, rarer outcome.6,9,11-13 People with CKD also have higher risk of acute kidney injury (AKI).13,14 AKI in those with existing CKD is associated with high morbidity and mortality.15,16


Treatment for Stage 3 CKD usually affects both kidneys. If the kidneys' ability to remove and regulate water and chemicals is seriously damaged by disease, waste products and excess fluid build up occur, causing severe swelling and symptoms of uremia (kidney failure).

http://www.sjzkidneyhospital.com/tags.php?/CKD+Treatment/

2015年1月17日星期六

Treatment for Stage 3 CKD have kidney damage

Treatment for Stage 3 CKD
CKD is a condition characterized by a progressive decline in kidney function. The kidney is normally responsible for excreting waste and excess water from the body, and for regulating various hormones. CKD is classified in five different stages — mild (stage 1) to severe (stage 5) disease — as measured by the kidney's glomerular filtration rate.

People with Treatment for Stage 3 CKD have kidney damage with normal or high GFR greater than 90 ml/min. They generally do not experience any symptoms of kidney damage even if the kidneys are no longer functioning at full capacity. Most people are diagnosed with Treatment for Stage 3 CKD in the process of being tested for another condition such as diabetes or high blood pressure, which are the two leading causes of kidney disease.

Many patients who develop Treatment for Stage 3 CKD have diabetes, high blood pressure or anemia. To help these patients to control their glucose level and keep a healthy blood pressure, some doctors will prescribe some medicine such as ACE and ARBs which can help the patients to control their high blood pressure, while other doctors will use some Chinese medicine and therapy such as Micro-Chinese Medicine Osmotherapy to adjust these patients' immunity, build their muscles, and then control their blood pressure and diabetes. Each treatment has its own advantages, so the patients can choose the right treatment according to their doctors.These steps may delay, or possibly halt, progression of the disease. Early referral to a nephrologist is of extreme importance.


http://www.sjzkidneyhospital.com/tags.php?/CKD+Treatment/

imperative in patients with Treatment for Stage 3 CKD

              CKD Treatment
Why are your kidneys so important?
Kidneys are the silent partner to good health! We can live quite well with only one kidney and indeed, some people live a healthy life even though born with one missing.
Treatment for Stage 3 CKD, the kidneys don't usually fail all at once. Instead, kidney disease often progresses slowly over a period of years. This is good news because if Treatment for Stage 3 CKD is caught early, medicines and lifestyle changes can possibly help delay disease progression Chronic kidney disease slowly becomes worse over time. Early diagnosis can help slow the progression of CKD and prolong kidney function.

Early diagnosis and treatment of the underlying cause and/or the institution of secondary preventive measures are imperative in patients with Treatment for Stage 3 CKD(CKD). These steps may delay, or possibly halt, progression of the disease. Early referral to a nephrologist is of extreme importance.

If you’ve recently been diagnosed with chronic kidney disease (CKD), one of the first things your doctor will do is determine how far the disease has progressed. When kidneys are damaged, they usually don’t fail all at once.
Also, a person might be referred to a dietician because diet is a very important part of treating kidney disease stage 3.

A healthy diet consisting of raw foods like fruits and vegetables, whole grains and lean meats is suggested for the patient so that the kidneys do not have to work as hard to break down fats and toxins.

http://www.sjzkidneyhospital.com/tags.php?/CKD+Treatment/

Awareness of Treatment for Stage 3 CKD

Treatment for Stage 3 CKD
Treatment for Stage 3 CKD is a disease whereby the kidneys have trouble removing waste products and fluid from the body. Awareness of Treatment for Stage 3 CKD has increased in part because of the definitions and treatment guidelines set out by Kidney Disease Outcomes Quality Initiative (KDOQI); however, the staging system set forth by these guidelines has led to several problems and unforeseen consequences.
Usual causes of CKD include Diabetes Mellitus, high blood pressure and chronic glomerulonephritis. People with CKD often have no symptoms although the kidney function is severely affected.

Awareness of chronic kidney disease (CKD) has increased in part because of the definitions and treatment guidelines set out by Kidney Disease Outcomes Quality Initiative (KDOQI); however, the staging system set forth by these guidelines has led to several problems and unforeseen consequences. Stages 1 and 2 CKD are difficult to determine using the standard Modification of Diet in Renal Disease (MDRD) estimation of GFR, and their clinical significance in the absence of other risk factors is unclear. The staging system needs to be modified to reflect the severity and complications of CKD. It is suggested that stages 1 and 2 be eliminated and Treatment for Stage 3 CKD, 4, and 5, be simply termed moderate impairment, severe impairment, and kidney failure, respectively. In addition, age should be a modifying factor, especially in moderate kidney impairment. These changes would allow identification and treatment of clinically relevant disease and avoidance of what can seem exaggerated prevalence estimates

Just because microalbuminuria in people without diabetes is a cardiovascular risk factor does not make it kidney disease. Most patients who receive a diagnosis of Treatment for Stage 3 CKD (GFR between 30 and 59 ml/min) are elderly people, and the vast majority of these patients will die before they reach ESRD. The staging system needs to be modified to reflect the severity and complications of CKD. It is suggested that stages 1 and 2 be eliminated and stages 3, 4, and 5, be simply termed moderate impairment, severe impairment, and kidney failure, respectively. In addition, age should be a modifying factor, especially in moderate kidney impairment. These changes would allow identification and treatment of clinically relevant disease and avoidance of what can seem exaggerated prevalence estimates

Stages 1 and 2 CKD are difficult to determine using the standard Modification of Diet in Renal Disease (MDRD) estimation of GFR, and their clinical significance in the absence of other risk factors is unclear. Just because microalbuminuria in people without diabetes is a cardiovascular risk factor does not make it kidney disease. Most patients who receive a diagnosis of Treatment for Stage 3 CKD (GFR between 30 and 59 ml/min) are elderly people, and the vast majority of these patients will die before they reach ESRD.

http://www.sjzkidneyhospital.com/tags.php?/CKD+Treatment/

2015年1月16日星期五

CKD can be roughly categorized as diminished renal reserve

treatment for Stage 4 CKD
Major trials of antidepressant treatment excluded patients with stages 3-5 CKD, precisely those at higher risk for both depression and increased mortality. The Chronic Kidney Disease Antidepressant Sertraline Trial (CAST) is a randomized, double-blinded, placebo-controlled trial of sertraline, a selective serotonin reuptake inhibitor (SSRI). It will enroll 200 adults with stages 3-5 CKD and MDD excluding kidney transplant and chronic dialysis patients.

CKD can be roughly categorized as diminished renal reserve, renal insufficiency, or renal failure (end-stage renal disease). Initially, as renal tissue loses function, there are few abnormalities because the remaining tissue increases its performance (renal functional adaptation); a loss of 75% of renal tissue causes a fall in GFR to only 50% of normal.

With more severe treatment for Stage 3 CKD(eg, creatinine clearance < 10 mL/min for patients without diabetes and < 15 mL/min for those with diabetes), neuromuscular symptoms may be present, including coarse muscular twitches, peripheral sensory and motor neuropathies, muscle cramps, hyperreflexia, restless legs syndrome, and seizures (usually the result of hypertensive or metabolic encephalopathy). Anorexia, nausea, vomiting, weight loss, stomatitis, and an unpleasant taste in the mouth are almost uniformly present. The skin may be yellow-brown. Occasionally, urea from sweat crystallizes on the skin (uremic frost). Pruritus may be especially uncomfortable. Undernutrition leading to generalized tissue wasting is a prominent feature of chronic uremia.

treatment for Stage 3 CKD is a common and serious condition that is often progressive among patients with CKD and it affects many of the approximately two million people throughout the world who are receiving dialysis.

http://www.sjzkidneyhospital.com/tags.php?/CKD+Treatment/

online doctor